Detalles de la búsqueda
1.
Identification of circulating tumor cells using 4-color fluorescence in situ hybridization: Validation of a noninvasive aid for ruling out lung cancer in patients with low-dose computed tomography-detected lung nodules.
Cancer Cytopathol
; 128(8): 553-562, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32320527
2.
Automated detection of genetic abnormalities combined with cytology in sputum is a sensitive predictor of lung cancer.
Mod Pathol
; 21(8): 950-60, 2008 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-18500269
3.
Surfactant protein A gene deletion and prognostics for patients with stage I non-small cell lung cancer.
Clin Cancer Res
; 11(15): 5417-24, 2005 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16061856
4.
Genetically abnormal circulating cells in lung cancer patients: an antigen-independent fluorescence in situ hybridization-based case-control study.
Clin Cancer Res
; 16(15): 3976-87, 2010 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20651054
5.
Comparison of molecular abnormalities in bronchial brushings and tumor touch preparations.
Cancer
; 105(1): 35-43, 2005 Feb 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-15605362
6.
Evaluation of peripheral blood involvement of mantle cell lymphoma by fluorescence in situ hybridization in comparison with immunophenotypic and morphologic findings.
Mod Pathol
; 17(5): 553-60, 2004 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-15001994
Resultados
1 -
6
de 6
1
Próxima >
>>